# US 2026/0085040 A1 · Amino acid and carbohydrate psilocin derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085040 A1
- Document ID: US20260085040A1
- Status: Published application
- Kind: A1
- Application number: 19/110,802
- Filed: 2023-09-11
- Published: 2026-03-26
- Earliest claimed: 2022-09-12
- Applicants: Bionxt Solutions Inc.
- Inventors: Raimar LOEBENBERG; Chuanjun GAO; Rong LING
- Web page: https://patentgrep.com/patent/US20260085040A1

## CPC

- C07D 209/16: Tryptamines
- A61P 25/24: Antidepressants
- C07D 209/20: substituted additionally by nitrogen atoms, e.g. tryptophane
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07H 17/02: Heterocyclic radicals containing only nitrogen as ring hetero atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

This disclosure relates to heterocyclic compounds of Formula (I) as well as the preparation and use thereof. As contemplated herein, heterocyclic compounds of Formula (I) can be any one of a carbohydrate conjugate and an amino acid conjugate. The heterocyclic compounds of Formula (I) may be used for the treatment of neuropsychiatric, and neurodegenerative, neuroinflammatory and pain disorders including depression, as well as tobacco, opiate, and cocaine addiction, alcoholism, post-traumatic stress disorder (PTSD), and pain syndromes including cluster headaches and chemotherapy induced peripheral neuropathy.

## Claims

### Claim 1

A chemical compound of Formula 1 selected from the group consisting of an amino acid ester and a carbohydrate conjugate:

### Claim 2 (depends on 1)

The chemical compound as claimed in claim 1, wherein Z is selected from the group consisting of C6H11O6—, C12H21O11—, C5H9O5—, and C5H9O4—.

### Claim 3 (depends on 2)

The chemical compound as claimed in claim 2, wherein Z is C6H11O6— and is selected from the group consisting of glucose, allose, altrose, mannose, gulose, idose, galactose, talose, psicose, fructose, sorbose, and tagatose, and derivatives of any one thereof.

### Claim 4 (depends on 2)

The chemical compound as claimed in claim 2, wherein the chemical compound is a glucose conjugate.

### Claim 5 (depends on 2)

The chemical compound as claimed in claim 2, wherein Z is C12H21O11— and is selected from the group consisting of trehalose, and sucrose, and derivatives of any one thereof.

### Claim 6 (depends on 2)

The chemical compound as claimed in claim 2, wherein Z is C5H9O5— and is selected from the group consisting of ribose, arabinose, xylose, lyxose, ribulose, and xylulose, and derivatives of any one thereof.

### Claim 7 (depends on 2)

The chemical compound as claimed in claim 2, wherein Z is C5H9O4— and is selected from the group consisting of ribose, arabinose, xylose, lyxose, ribulose, and xylulose, and derivatives of any one thereof.

### Claim 8 (depends on 1)

The chemical compound as claimed in claim 1, wherein: (i) Z is selected from the group consisting of C6H13N4O2—, C6H9N3O2—, C6H13N2O2—, C4H8NO4—, C5H3NO4—, C3H7NO3—, C4H8NO3—, C4H7N2O3—, C5H9N2O3—, C3H6NO2X—, C2H4NO2—, C5H8NO2—, C5H8NO3—, C3H6NO2—, C5H10NO2—, C6H12NO2—, C5H10NO2S—, C9H10NO2—, C9H10NO3—, and C11H11N2O2—, and derivatives of any one thereof; and (ii) X can be selected from the group consisting of S and Se.

### Claim 9 (depends on 8)

The chemical compound as claimed in claim 8, wherein the chemical compound is selected from the group consisting of a proline ester, a valine ester, and derivatives of any one thereof.

### Claim 10 (depends on 8)

The chemical compound as claimed in claim 8, wherein the chemical compound is a valine ester.

### Claim 11 (depends on 1)

The chemical compound as claimed in claim 1, wherein the chemical compound is selected from the group consisting of an alanine conjugate, deoxyribose conjugate, glycine conjugate, hydroxyproline conjugate, leucine conjugate, methionine conjugate, phenylalanine conjugate, proline conjugate, ribose conjugate, serine conjugate, tryptophan conjugate, and valine conjugate.

### Claim 12 (depends on 1)

The chemical compound as claimed in claim 1, wherein the chemical compound is selected from the group consisting of a deoxyribose conjugate and hydroxyproline conjugate and ribose conjugate.

### Claim 13 (depends on 1)

The chemical compound as claimed in claim 1, wherein the chemical compound is selected from the group consisting of a phenylalanine conjugate, proline conjugate, and tryptophan conjugate.
